Guided Therapeutics, Inc. Stock
Stocks
GTHP
US40171F5017
Advanced Medical Equipment & Technology
OTC Markets Traded|
Real-time
OTC Markets
12:12:26 2026-05-29 EDT
|
5-day change | 1st Jan Change | ||
| 0.2290 USD | -.--% |
|
+34.71% | -57.59% |
| Market Cap | 13.97M 12.51M 11.51M 10.43M 19.49M 1.33B 19.85M 137M 55.08M 698M 52.42M 51.31M 2.2B | P/E 2024 |
-3x | P/E 2025 | -12.7x |
|---|---|---|---|---|---|
| Enterprise Value | 16.84M 15.09M 13.88M 12.57M 23.5M 1.6B 23.94M 165M 66.43M 841M 63.21M 61.87M 2.65B | EV / Sales 2024 |
1,649x | EV / Sales 2025 | 64.4x |
| Free-Float |
63.48% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 week | +34.71% | ||
| Current month | -7.62% | ||
| 1 month | +14.50% | ||
| 3 months | -23.67% | ||
| 6 months | +14.50% | ||
| Current year | -57.59% |
| 1 week | 0.13 | 0.23 | |
| 1 month | 0.13 | 0.24 | |
| Current year | 0.13 | 0.54 | |
| 1 year | 0.13 | 0.54 | |
| 3 years | 0.06 | 0.54 | |
| 5 years | 0.06 | 0.78 | |
| 10 years | 0.02 | 3,200 |
| Manager | Title | Age | Since |
|---|---|---|---|
Mark Faupel
CEO | Chief Executive Officer | 70 | 2023-03-05 |
| Chief Tech/Sci/R&D Officer | 70 | 2010-12-01 |
| Director | Title | Age | Since |
|---|---|---|---|
Mark Faupel
BRD | Director/Board Member | 70 | 2016-11-30 |
John Imhoff
BRD | Director/Board Member | 76 | 2006-04-09 |
Michael James
CHM | Chairman | 67 | 2013-09-30 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 3/10/26 | Free | Chairman | 110,000 | 0.1316% | ||
| 3/10/26 | Others | Director | 466,991 | 0.5586% | ||
| 3/10/26 | Free | Director | 110,000 | 0.1316% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -.--% | +34.71% | -0.43% | +37.13% | 13.97M | ||
| -1.45% | +3.78% | +25.72% | +61.08% | 262B | ||
| -2.22% | +0.72% | +7.96% | +25.43% | 167B | ||
| -2.61% | -3.53% | -17.67% | +68.80% | 156B | ||
| -1.45% | -7.78% | -58.10% | -15.81% | 61.87B | ||
| -1.67% | +4.22% | +11.20% | +48.86% | 54.44B | ||
| 0.00% | +2.46% | -11.97% | -6.29% | 53.3B | ||
| -3.49% | +1.12% | +22.07% | +72.98% | 51.07B | ||
| +0.29% | -3.90% | +8.91% | +63.15% | 50.25B | ||
| -3.75% | +1.69% | +34.54% | +94.90% | 47.17B | ||
| Average | -1.65% | +1.52% | +2.22% | +45.02% | 90.26B | |
| Weighted average by Cap. | -1.87% | +2.44% | +5.43% | +48.40% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 7K 6.27K 5.77K 5.23K 9.77K 665K 9.95K 68.77K 27.61K 350K 26.27K 25.71K 1.1M | 767K 687K 632K 573K 1.07M 72.83M 1.09M 7.54M 3.02M 38.31M 2.88M 2.82M 121M |
| Net income | -2.42M -2.16M -1.99M -1.8M -3.37M -229M -3.44M -23.74M -9.53M -121M -9.07M -8.88M -381M | -3.2M -2.86M -2.63M -2.39M -4.46M -303M -4.54M -31.4M -12.6M -160M -11.99M -11.74M -503M |
| Net Debt | 1.77M 1.59M 1.46M 1.32M 2.47M 168M 2.52M 17.4M 6.98M 88.46M 6.65M 6.51M 279M | 2.88M 2.58M 2.37M 2.15M 4.01M 273M 4.09M 28.25M 11.34M 144M 10.79M 10.56M 453M |
Employees
3
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-29 | US$0.1447 | -1.69% | 1,000 |
| 26-10-28 | US$0.1472 | +1.48% | 1,951 |
| 26-10-27 | US$0.1450 | +9.95% | 1,127 |
| 26-10-26 | US$0.1319 | -9.03% | 1,003 |
| 26-10-23 | US$0.1450 | -14.71% | 10,272 |
- Stock Market
- Stocks
- GTHP Stock
Select your edition
All financial news and data tailored to specific country editions
















